Laxmi Patel explains how providers can meet potential new Medicaid documentation requirements without harming patient access.
Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast ...
Conavi Medical has submitted its Novasight Hybrid™ IVUS/OCT intravascular imaging system to the US Food and Drug ...
These pioneers are aiming to do challenging and important medical work. One has already implanted 54 patients.
According to Precedence Research, the global cord blood banking services market size will grow from USD 3.27 billion in 2025 to nearly USD 5.81 billion by 2034, with a CAGR of 6.61%. Driven by the ...
Conavi announced today that it submitted its next-generation Novasight Hybrid intravascular imaging system for FDA 510(k) ...
Submission Follows the Successful Validation Testing with KOLs FDA 510(k) Clearance Anticipated During H1 2026 and Company ...
This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...
But today, thanks to a research lab at California Institute of Technology (Caltech) that implanted him with a brain computer interface ... Food and Drug Administration (FDA), including some staff ...
FDA assigns a Prescription Drug User Fee Act (PDUFA) date of July 11, 2026 REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged ...
Imported ingredients not on the green list of active pharmaceutical ingredients in GLP-1 drugs in compliance with FDA standards will be subject to detention without examination at the border.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback